EspeRare at the World Health Assembly: Advancing Global Momentum for Rare Diseases
EspeRare at the World Health Assembly: Advancing Global Momentum for Rare Diseases
EspeRare is proud to announce its participation in the landmark side event “Milestones & Momentum in Rare Diseases: 10 Years of Progress, 10 Years of Possibility” taking place during the 78th World Health Assembly (WHA78) on May 21st, 2025, in Geneva and online. This pivotal gathering, organized by Rare Diseases International and leading global partners, marks a historic milestone as the WHA prepares to vote on a global Resolution for Rare Diseases.
Caroline Kant, CEO and Founder of EspeRare, will join global leaders and advocates on the panel “Expanding Access to Care & Treatment: Ambitious Solutions for Global Impact,” sharing EspeRare’s pioneering work in equitable models for therapeutic development and access to medicine and its commitment to sustainable innovation in rare diseases and prenatal therapy.
As the world edges closer to the adoption of the first-ever WHO Global Action Plan on Rare Diseases, this event celebrates a decade of collective progress and defines the path forward. At EspeRare, we are honored to contribute to this global dialogue and reaffirm our mission: making hope tangible for underserved patients, especially those affected by rare paediatric and prenatal conditions.
Event: WHA78 Side Event – “Milestones & Momentum in Rare Diseases”
Date: May 21, 2025 from 6-7:45pm
Location: La Pastorale, Geneva & register to participate online